APPLICATION
ANDA077323
TYPE
ANDA
ORIGINAL APPROVAL
2006-04-20
LATEST ACTION
2017-12-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CILOSTAZOLDiscontinued
CILOSTAZOL 100MG · TABLET · ORAL
CILOSTAZOLDiscontinued
CILOSTAZOL 50MG · TABLET · ORAL
Approval history
2017-12-28Labeling · Supplement 7 · standardAP
2017-12-28Labeling · Supplement 8 · standardAP
2011-05-10Labeling · Supplement 6AP
2010-08-31Labeling · Supplement 5AP
2006-04-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.